标题
Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 20, Issue 11, Pages 1283-1285
出版商
Informa UK Limited
发表日期
2016-09-22
DOI
10.1080/14728222.2016.1239719
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer
- (2016) S. Jagadeeshan et al. ANNALS OF ONCOLOGY
- FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine
- (2016) Dannel Yeo et al. BMC CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo
- (2016) Ahmad Al-Azayzih et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeting PAK1 in pancreatic stellate cells increases pancreatic cancer survival
- (2016) Dannel Yeo et al. PANCREATOLOGY
- The Role of p21-Activated Kinases in Pancreatic Cancer
- (2015) Dannel Yeo et al. PANCREAS
- Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor
- (2015) Alexei S. Karpov et al. ACS Medicinal Chemistry Letters
- Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pKa Polar Moiety
- (2015) Chudi O. Ndubaku et al. ACS Medicinal Chemistry Letters
- Molecular Pathways: Targeting RAC-p21-Activated Serine-Threonine Kinase Signaling in RAS-Driven Cancers
- (2014) N. M. Baker et al. CLINICAL CANCER RESEARCH
- Pancreatic stellate cells and pancreas cancer: Current perspectives and future strategies
- (2014) Jonathan Haqq et al. EUROPEAN JOURNAL OF CANCER
- Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis
- (2014) S Jagadeeshan et al. ONCOGENE
- FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
- (2013) Silvia Licciulli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IPA-3 Inhibits the Growth of Liver Cancer Cells By Suppressing PAK1 and NF-κB Activation
- (2013) Leo Lap-Yan Wong et al. PLoS One
- Pancreatic cancer: why is it so hard to treat?
- (2013) Paul E. Oberstein et al. Therapeutic Advances in Gastroenterology
- p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model
- (2012) H. Y. Chow et al. CANCER RESEARCH
- Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--Opportunities, Challenges, and Limitations
- (2012) J. Eswaran et al. CLINICAL CANCER RESEARCH
- An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently
- (2009) J. Viaud et al. MOLECULAR CANCER THERAPEUTICS
- An Isoform-Selective, Small-Molecule Inhibitor Targets the Autoregulatory Mechanism of p21-Activated Kinase
- (2008) Sean W. Deacon et al. CHEMISTRY & BIOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started